Over 1150 Total Lots Up For Auction at Three Locations - WI 07/09, NJ Cleansweep 07/10, CA 07/11

Conférence 2009 d'investissement et de partenariat de l'industrie de Neurotech

par Lynn Shapiro, Writer | March 27, 2009
Moderator: Dan O'Connell, Managing Partner, NeuroVentures Capital

Neuroregeneration and Stem Cells:
Deborah Eppstein, President and CEO, Q Therapeutics
Andres Haegerstrand, Chief Scientific Officer, NeuroNova
stats Advertisement
DOTmed text ad

Ensure critical devices are ready to go

Keep biomedical devices ready to go, so care teams can be ready to care for patients. GE HealthCare’s ReadySee™ helps overcome frustrations due to lack of network and device visibility, manual troubleshooting, and downtime.

stats Advertisement

Jonathan Kil, President and CEO, Sound Pharmaceuticals
Martin McGlynn, President and CEO, StemCells, Inc.
Session Chair: Frank Eeckman, NeuroInsights, NIO

NeuroVaccines, The Use of Vaccines in Neurology and Psychiatry:
Raafat Fahim, President and CEO, Nabi
Mark Schwartz, President and CEO, Bayhill Therapeutics
Walter Schmidt, CEO, Affiris
Session Chair: Roger Quy, General Partner, Technology Partners

Traumatic Injury: Stroke, Traumatic Brain Injury, and Spinal Cord Injury:
Martin Dieck, President and CEO, Nfocus Neuromedical
Shawn Lunney, CEO, Neurolutions
Vincent Simmon, President and CEO, Xytis
Michael Singer, CEO, BrainScope
Session Chair: Teo Forcht Dagi, Partner, HLM Venture Partners

Neuroscience Translation, Tech Transfer and Collaboration Opportunities:
Jamie Driscoll, Chief of Research Services, NIMH
Jill Heemskerk, Acting Director, Office of Translational Research, NINDS
Joe Pancrazio, Program Director, Extramural, Repair & Plasticity Cluster,
NINDS Session Chair: Melissa Maderia, Technology Transfer Specialist, NINDS

And that's just for starters.

Back to HCB News